Maderazo, Gregorio V.

HRN: 22 27 18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
CEFTAZIDIME 1GM (VIAL)
04/19/2026
04/25/2026
IV
1gm
BID
Cap MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: